Adaptive Insulin Management for Specialized Environments

Publication ID: 24-11857314_0004_PTD
Published: November 07, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Insulin Management for Specialized Environments,” Published Technical Disclosure No. 24-11857314_0004_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857314_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,314.

Summary of the Inventive Concept

The present inventive concept adapts insulin management systems for specific, narrow markets or unique operational environments, providing tailored solutions for high-security facilities, disaster relief situations, extreme weather conditions, trauma patients, and remote or isolated areas.

Background and Problem Solved

The original insulin management patent addresses the critical issue of manually calculating insulin doses, but it lacks consideration for specialized environments that require adapted solutions. The present inventive concept addresses this limitation by providing customized insulin management systems that cater to specific operational environments, ensuring more effective and efficient patient care.

Detailed Description of the Inventive Concept

The inventive concept comprises a suite of specialized insulin management systems, each tailored to a specific environment. For high-security facilities, the system incorporates a secure database and communication protocol to protect patient records and ensure authorized access. In disaster relief situations, the system utilizes a portable glucose monitoring system and cloud-based insulin dosing algorithm to provide real-time dosing recommendations. For extreme weather conditions, the system features a weather-resistant housing and backup power source to ensure continuous operation. For patients with fluctuating blood sugars due to trauma, the system employs a machine learning algorithm to analyze patient data and adjust insulin dosing recommendations based on the patient's response to treatment. Finally, for remote or isolated areas, the system incorporates a satellite-based communication system to transmit patient data and receive insulin dosing recommendations from a remote clinical decision support system.

Novelty and Inventive Step

The present inventive concept introduces novel adaptations to insulin management systems, addressing specific challenges posed by unique operational environments. The inventive step lies in the customized solutions provided for each environment, which are not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating wearable glucose monitoring devices, utilizing artificial intelligence to predict insulin dosing needs, or incorporating environmental sensors to adjust insulin dosing recommendations based on external factors.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in various industries, including healthcare, disaster relief, and defense. The target market includes high-security facilities, disaster relief organizations, extreme weather response teams, trauma centers, and remote or isolated healthcare providers.

Original Patent Information

Patent NumberUS 11,857,314
TitleInsulin management
Assignee(s)Aseko, Inc.